- Home
- MDCX vs RGNT Comparison
MDCX vs RGNT Comparison
Compare MDCX & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDCX | RGNT |
|---|---|---|
| Founded | 2008 | 2004 |
| Country | United States | Israel |
| Employees | N/A | 8 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9M | 14.3M |
| IPO Year | 2025 | 2022 |
Fundamental Metrics
Financial Performance| Metric | MDCX | RGNT |
|---|---|---|
| Price | $0.15 | $2.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 5.6M | 37.0K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.14 | $1.23 |
| 52 Week High | $2.78 | $15.50 |
Technical Indicators
Market Signals| Indicator | MDCX | RGNT |
|---|---|---|
| Relative Strength Index (RSI) | 29.90 | 48.68 |
| Support Level | $0.15 | $1.74 |
| Resistance Level | $0.19 | $2.54 |
| Average True Range (ATR) | 0.01 | 0.15 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 14.70 | 34.67 |
Price Performance
Historical ComparisonAbout MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
About RGNT Regentis Biomaterials Ltd. Ordinary Shares
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.